StockIQpro
NASDAQ:PODD

Insulet Corp.

Insulet Corp.'s revenue grew 30.7% in fiscal 2025 to $2.7B while operating margin rose to 17.5%, its highest in 10 years. Free cash flow was $377.7M, 13.9% of revenue, and the diluted share count fell 2.7%.Summary generated from Insulet Corp.'s SEC filings. Latest annual report filed Feb 18, 2026.

Revenue (FY25)$2.7B
Revenue growth+30.7%
Revenue, 5-yr CAGR+24.5%
Gross margin71.6%
Operating margin17.5%
Net margin9.1%
ROIC20.4%
Return on equity18.1%
Debt / equity0.63
Free cash flow$377.7M
FCF margin13.9%
Share count change−2.7%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue1,0991,3051,6972,0722,708
Operating income12638220309474
Net income175206418247
Free cash flow−180−470305378

Recent filings

From SEC EDGAR

Peers

Surgical & medical instruments & apparatus